Michael D. West Ph.D.
Net Worth

Last updated:

What is Michael D. West Ph.D. net worth?

The estimated net worth of Dr. Michael D. West Ph.D. is at least $3,927,210 as of 11 Mar 2023. He has received compensation worth at least $3,927,210 in AgeX Therapeutics, Inc..

What is the salary of Michael D. West Ph.D.?

Dr. Michael D. West Ph.D. salary is $561,030 per year as Founder, Pres, Chief Executive Officer & Director in AgeX Therapeutics, Inc..

How old is Michael D. West Ph.D.?

Dr. Michael D. West Ph.D. is 72 years old, born in 1953.

What stocks does Michael D. West Ph.D. currently own?

As insider, Dr. Michael D. West Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
AgeX Therapeutics, Inc. (AGE) Founder, Pres, Chief Executive Officer & Director 15,460 $0 $0

What does AgeX Therapeutics, Inc. do?

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550, a gene delivery technology. The company has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California.

AGE logo
AGE
AgeX Therapeutics, Inc.

Michael D. West Ph.D. insider trading

AgeX Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Common Stock, $0.0001 par value 3,125 N/A N/A
Option
Restricted Stock Units 12,500 N/A N/A
Option
Common Stock, $0.0001 par value 12,500 N/A N/A
Purchase
Common Stock, $0.0001 par value 4,000 N/A N/A

AgeX Therapeutics key executives

AgeX Therapeutics, Inc. executives and other stock owners filed with the SEC: